Pathways of cancer cell evolution
101 – 110 of 127
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages
(
- Contribution to journal › Article
-
Mark
Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
(
- Contribution to journal › Article
- 2019
-
Mark
Identification of targetable lesions in anaplastic thyroid cancer by genome profiling
(
- Contribution to journal › Article
-
Mark
Clonal evolution through genetic bottlenecks and telomere attrition : Potential threats to in vitro data reproducibility
(
- Contribution to journal › Scientific review
-
Mark
Changes in the Prevalence of Embryologic Remnants in Umbilical Cord With Gestational Age
(
- Contribution to journal › Article
-
Mark
The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis
(
- Contribution to journal › Article
-
Mark
Multidimensional intratumour heterogeneity in neuroblastoma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Immune effector monocyte–neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer
2019) In Proceedings of the National Academy of Sciences of the United States of America 116(43). p.21704-21714(
- Contribution to journal › Article
- 2018
-
Mark
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
(
- Contribution to journal › Article
-
Mark
Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers
(
- Contribution to journal › Article